Seligdar (T+: Odd lots)/ RU000A0JPR50 /
2024-06-20 6:31:51 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
69.76RUB | - | 3 Turnover: 204.74 |
-Bid Size: - | -Ask Size: - | 69.76 | 66.70 |
GlobeNewswire
1:15 AM
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
1:10 AM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
12:45 AM
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
12:38 AM
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
12:30 AM
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...
GlobeNewswire
12:24 AM
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against UiPath, Inc. (...
GlobeNewswire
12:00 AM
KIP Protocol Partners with Open Campus to Launch Open Campus U, Transforming Education Through Decen...
GlobeNewswire
06-21
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
06-21
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against NIKE, Inc. (NK...
GlobeNewswire
06-21
NIKE, INC. (NYSE: NIKE) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Act...
GlobeNewswire
06-21
Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
06-21
In Major Victory For Injured Owners of “Dangerously Defective” Firearm, Federal Jury Awards $2.35 Mi...
GlobeNewswire
06-21
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
06-21
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Sharehold...
GlobeNewswire
06-21
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...